UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000039683 |
|---|---|
| Receipt number | R000045262 |
| Scientific Title | Competing interests among Authors of Clinical Practice Guidelines for Dermatology Update Guidelines produced between 2017 and 2019 |
| Date of disclosure of the study information | 2020/03/03 |
| Last modified on | 2020/03/03 23:14:40 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Competing interests among Authors of Clinical Practice Guidelines for Dermatology Update Guidelines produced between 2017 and 2019
Acronym
Competing interests among Authors of Clinical Practice Guidelines for Dermatology Update Guidelines produced between 2017 and 2019
Scientific Title
Competing interests among Authors of Clinical Practice Guidelines for Dermatology Update Guidelines produced between 2017 and 2019
Scientific Title:Acronym
Competing interests among Authors of Clinical Practice Guidelines for Dermatology Update Guidelines produced between 2017 and 2019
Region
| North America |
Condition
Condition
This article examines FCOIs among authors of dermatological CPGs (new or updated) published from 2017-2019 to determine their continued presence after the original article was published.
Classification by specialty
| Dermatology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This article examines FCOIs among authors of dermatological CPGs (new or updated) published from 2017-2019 to determine their continued presence after the original article was published..
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
This article examines FCOIs among authors of dermatological CPGs (new or updated) published from 2017-2019 to determine their continued presence after the original article was published.
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 99 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Clinical Practice Guidelines for Dermatology published between 2017 and 2019
Key exclusion criteria
Clinical Practice Guidelines for Dermatology published between 2017 and 2019
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Micah |
| Middle name | |
| Last name | Hartwell |
Organization
Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma. 1111 W 17th St. Tulsa, OK 74107
Division name
CHS
Zip code
74107
Address
1111 West 17th Street
TEL
9185948426
micah.hartwell@okstate.edu
Public contact
Name of contact person
| 1st name | Matt |
| Middle name | |
| Last name | Vassar |
Organization
Oklahoma State University
Division name
CHS
Zip code
74107
Address
1111 West 17th Street
TEL
9185948426
Homepage URL
matt.vassar@okstate.edu
Sponsor or person
Institute
Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma. 1111 W 17th St. Tulsa, OK 74107
Institute
Department
Personal name
Funding Source
Organization
Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma. 1111 W 17th St. Tulsa, OK 74107
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
OSU
Address
111 W 174th st
Tel
9185948426
matt.vassar@okstate.edu
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 03 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2020 | Year | 03 | Month | 03 | Day |
Date of IRB
Anticipated trial start date
| 2020 | Year | 03 | Month | 04 | Day |
Last follow-up date
| 2021 | Year | 03 | Month | 03 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
his article examines FCOIs among authors of dermatological CPGs (new or updated) published from 2017-2019 to determine their continued presence after the original article was published
Management information
Registered date
| 2020 | Year | 03 | Month | 03 | Day |
Last modified on
| 2020 | Year | 03 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045262
